AT₁ Antibodies

Santa Cruz Biotechnology provides a broad selection of AT₁ monoclonal antibodies for investigating the angiotensin II type 1 receptor. AT₁ monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The angiotensin II type 1 receptor plays a critical role in regulating blood pressure and fluid balance, making it a significant target in cardiovascular research. Dysregulation of AT₁ can lead to various pathophysiological conditions, including hypertension and heart failure. Understanding the function and signaling pathways of AT₁ receptor is essential for developing therapeutic strategies against cardiovascular diseases. AT₁ monoclonal antibodies enable precise detection and characterization of AT₁ receptor expression patterns across different tissues and experimental conditions. Researchers can leverage AT₁ monoclonal antibodies to explore receptor localization, protein-protein interactions, and signaling cascades. AT₁ monoclonal antibodies from Santa Cruz Biotechnology contribute to advancing cardiovascular research and the development of targeted therapeutic approaches.